English 
Spain 
Deutsch
GET A QUOTE
Adhering to the service tenet of "Integrity, Innovation, Harmony, and Win-win", We have established a complete one-stop procurement and comprehensive solution service system.
Description
Basic Info.
Retatrutide is an experimental drug developed by Eli Lilly and Company in the United States for the treatment of obesity. It is a triple glucagon hormone receptor agonist.
In a phase II clinical trial, the drug has been proved to reduce the average weight of non diabetes but obese or pre obese (overweight) adults by more than 17.5%
RTL Version
- RTL Version
- LTR Version
Send A Message
We'd love to hear from you if you have any questions!
Related Products
Hyaluronic acid
FG Loop(FGL)
HMG
snap-8